A review of malaria vaccine clinical projects based on the WHO rainbow table
about
Immune mechanisms in malaria: new insights in vaccine developmentNeed of cost-effective vaccines in developing countries: What plant biotechnology can offer?The Use of Synthetic Carriers in Malaria Vaccine DesignMalaria endemicity and co-infection with tissue-dwelling parasites in Sub-Saharan Africa: a reviewApplication of radiation technology in vaccines developmentProfiling the host response to malaria vaccination and malaria challengePaths to a malaria vaccine illuminated by parasite genomicsVaccines against malariaRecent advances in malaria drug discoveryA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesTpUB05, a Homologue of the Immunodominant Plasmodium falciparum Protein UB05, Is a Marker of Protective Immune Responses in Cattle Experimentally Vaccinated against East Coast FeverRegulation of Plasmodium falciparum development by calcium-dependent protein kinase 7 (PfCDPK7)Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formationAdvances in genetics and genomics: use and limitations in achieving malaria elimination goalsNew targets for drug discovery against malariaTheoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparumA member of the CPW-WPC protein family is expressed in and localized to the surface of developing ookinetesYeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.Malaria vaccine: a step toward elimination.Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.Malaria vaccine research and development: the role of the WHO MALVAC committeeProduction and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24Plasmodium vivax antigen discovery based on alpha-helical coiled coil protein motifVirus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmissionDynamics in multiplicity of Plasmodium falciparum infection among children with asymptomatic malaria in central Ghana.Strategies for designing and monitoring malaria vaccines targeting diverse antigensGeneration of rodent malaria parasites with a high mutation rate by destructing proofreading activity of DNA polymerase δ.Allelic Forms of Merozoite Surface Protein-3 in Plasmodium falciparum Isolates From Southeast of Iran.Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisVaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelHigh-throughput tri-colour flow cytometry technique to assess Plasmodium falciparum parasitaemia in bioassays.Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2.Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines.Disruption of cellular homeostasis induces organelle stress and triggers apoptosis like cell-death pathways in malaria parasiteAssessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparumEfficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis.A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.The case for a rational genome-based vaccine against malaria.
P2860
Q21032484-D73345BB-5CB9-47B8-A58F-3FA8D1150598Q26769942-A17ABB33-0D96-4E60-A606-47D80119F627Q26777053-FA9E0952-3EB3-45CB-845D-5AF5DA3EBC10Q26786020-D551B22A-5238-48E3-A65B-582B5ECAC924Q26798165-2549A154-D63E-41E4-BBBB-A728BE3171FFQ26800494-00B535CA-9500-4E73-8C90-ECBF88CDE868Q26853267-E65F4828-F983-4D40-82FA-70F8F136ABFCQ26995079-08D0085A-4BC2-4923-A9B3-049A63B39414Q27010534-3BDB11FC-D61E-44A4-A4EB-66BEE9F5E6B3Q27303293-0FC0930D-F3D6-4ED4-A879-0A63282ED539Q27305881-DBB4F29A-34A6-4FA0-915E-DB929AC4B4B5Q27972855-B1DE2A1B-DF66-4E70-8185-B3464264553AQ27974527-FEAE6682-B2BC-402F-80B4-1BF3120DC149Q28082023-6CF560B1-B215-4500-82D4-68E08EF483E2Q28489108-2C3EEE34-EF69-49E0-BC72-BA8B962EE786Q28541220-FCA56AAE-0BD7-4F90-9451-7A34CD9C94C6Q30042193-82C05B90-454E-4445-A603-DC0D6CF1E142Q32175658-2825BC0E-E860-4E8F-95C4-2B9955B2D691Q33577978-429CC0F7-A5D2-4A69-82D5-4512A9DAF39EQ33590453-E2D4D26D-F73F-4AB1-B747-D52875286958Q33611463-566EA03C-1076-4611-BF51-47A7EB5DAB2FQ33743450-F753DC22-DF39-441D-9B32-8E79185E57F3Q33800285-C6DB8668-BC7A-4694-A215-D4BC381E461AQ33855899-7A171B75-EDB4-409E-9CDA-18D21A7AABD0Q33859217-C3DCD6C7-C9AF-4854-95CD-4946343097F7Q33913006-85E74072-BF36-4F6D-97B0-518461D4B74AQ33959038-6B089CEB-5EF9-44CD-BF74-301EB6747674Q34040908-F8DB6286-6636-4A8D-B0D4-B4340F2A470CQ34068587-6C6D73A2-C5B3-41F9-8AEA-D253E4DA9CD2Q34234390-724010E0-A417-4509-BE17-7F823CB8B14DQ34398787-E99A2D28-4ABF-4890-BC65-0CADDF544292Q34423023-C7761BC7-E2A3-436F-AB2F-BFF561E26A0EQ34471140-AA1D684B-96BB-48A9-8581-C2765D6AE34DQ34478487-3EDF4551-1898-45E8-A266-E2C0D34E39C8Q34483288-195B6170-FD79-48C3-B532-C48A0EE4B3B5Q34484078-8FE27D54-C458-4285-B89D-6F21C44AABF7Q34548672-D6E89BEF-7E1E-4491-B2E8-0B3DB123CB65Q34734075-C3C9816D-6B5B-45E1-9FBA-A78474CE7134Q34749432-327FE337-3461-495C-81C7-49E6F8EDD50BQ34999392-E9015EE0-ACCD-44FD-AC83-5BB6A2390FC4
P2860
A review of malaria vaccine clinical projects based on the WHO rainbow table
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A review of malaria vaccine clinical projects based on the WHO rainbow table
@ast
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en-gb
A review of malaria vaccine clinical projects based on the WHO rainbow table
@nl
type
label
A review of malaria vaccine clinical projects based on the WHO rainbow table
@ast
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en-gb
A review of malaria vaccine clinical projects based on the WHO rainbow table
@nl
prefLabel
A review of malaria vaccine clinical projects based on the WHO rainbow table
@ast
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en-gb
A review of malaria vaccine clinical projects based on the WHO rainbow table
@nl
P2860
P50
P921
P3181
P356
P1433
P1476
A review of malaria vaccine clinical projects based on the WHO rainbow table
@en
P2093
Lauren Schwartz
P2860
P2888
P3181
P356
10.1186/1475-2875-11-11
P407
P5008
P577
2012-01-09T00:00:00Z
P5875
P6179
1024029582